• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过荧光原位杂交检测膀胱癌中的9号染色体缺失。

Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer.

作者信息

Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch M J, Waldman F M

机构信息

Institute of Pathology, University of Basel, Switzerland.

出版信息

Int J Cancer. 1995 Apr 21;64(2):99-103. doi: 10.1002/ijc.2910640205.

DOI:10.1002/ijc.2910640205
PMID:7615360
Abstract

A loss of chromosome-9 material is one of the most frequent genomic aberrations known in bladder cancer. In order to better understand the role of chromosome-9 losses in bladder cancer, 125 formalin-fixed and 37 unfixed bladder tumors were examined using fluorescence in situ hybridization (FISH). A repetitive probe for a pericentromeric region on 9q12 (pHUR98) was applied for chromosome-9 copy-number enumeration. Under-representation of chromosome 9 was found in 74 of 162 cases. There was no association between loss of chromosome 9 and increased grade or stage, papillary growth pattern, p53 protein expression, or tumor-cell proliferation (Ki-67). These data show that chromosome-9 loss is an early event in bladder-cancer development, occurring independently of p53 alterations. In order to determine the prevalence of large sub-regional chromosome-9 deletions, dual hybridizations with pHUR98 and cosmid probes for 9q34, 9q22, and 9p21 were performed. Partial deletion was detected in only 1 of 36 cases for 9q34 and in 1 of 24 cases for 9p21. Surprisingly, amplification of the interferon alpha locus on 9p21 was seen in 1 of 24 tumors. The finding of 9p amplification may indicate the site of an oncogene relevant for bladder cancer.

摘要

9号染色体物质缺失是膀胱癌中已知的最常见基因组畸变之一。为了更好地理解9号染色体缺失在膀胱癌中的作用,我们使用荧光原位杂交(FISH)技术检测了125例福尔马林固定和37例未固定的膀胱肿瘤。应用针对9q12上着丝粒周围区域的重复探针(pHUR98)对9号染色体进行拷贝数计数。在162例病例中,有74例发现9号染色体呈现低拷贝数。9号染色体缺失与肿瘤分级或分期增加、乳头状生长模式、p53蛋白表达或肿瘤细胞增殖(Ki-67)之间均无关联。这些数据表明,9号染色体缺失是膀胱癌发生发展过程中的早期事件,其发生独立于p53改变。为了确定9号染色体大片段亚区域缺失的发生率,我们使用pHUR98和针对9q34、9q22及9p21的黏粒探针进行了双重杂交。在36例检测9q3�的病例中仅1例检测到部分缺失,在24例检测9p21的病例中也仅1例检测到部分缺失。令人惊讶的是,在24例肿瘤中有1例发现9p21上的干扰素α基因座发生扩增。9p扩增的发现可能提示了一个与膀胱癌相关的癌基因位点。

相似文献

1
Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer.通过荧光原位杂交检测膀胱癌中的9号染色体缺失。
Int J Cancer. 1995 Apr 21;64(2):99-103. doi: 10.1002/ijc.2910640205.
2
Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.采用荧光原位杂交技术检测临床膀胱癌标本中9p21和9q33染色体带的改变。
Clin Cancer Res. 2001 Jun;7(6):1676-82.
3
Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.荧光原位杂交检测到膀胱癌患者组织学正常的膀胱尿路上皮中频繁出现9号染色体缺失和非整倍体。
Oncol Rep. 2004 Apr;11(4):745-51.
4
Identification of chromosome 9 alterations and p53 accumulation in isolated carcinoma in situ of the urinary bladder versus carcinoma in situ associated with carcinoma.孤立性膀胱原位癌与伴发癌的原位癌中9号染色体改变及p53蓄积的鉴定
Am J Pathol. 2002 Oct;161(4):1119-25. doi: 10.1016/S0002-9440(10)64388-X.
5
Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization.膀胱癌中p53基因的物理缺失。通过荧光原位杂交进行检测。
Am J Pathol. 1994 Apr;144(4):756-66.
6
Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization.通过荧光原位杂交检测浅表性膀胱癌中细胞周期蛋白依赖性激酶抑制剂2(MTS1,p16)的频繁纯合缺失。
Genes Chromosomes Cancer. 1997 Jun;19(2):84-9.
7
Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.人膀胱多灶发育异常及原位癌中9号染色体和p53改变的发生情况。
Cancer Res. 2002 Feb 1;62(3):809-18.
8
High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.膀胱鳞状细胞癌中9号染色体短臂等位基因缺失及CDKN2肿瘤抑制基因改变的高频率。
J Natl Cancer Inst. 1995 Sep 20;87(18):1383-93. doi: 10.1093/jnci/87.18.1383.
9
Y chromosome loss detected by FISH in bladder cancer.通过荧光原位杂交(FISH)检测到膀胱癌中的Y染色体缺失。
Cancer Genet Cytogenet. 1995 Jul 15;82(2):163-9. doi: 10.1016/0165-4608(95)00030-s.
10
Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.通过组织病理学器官定位、杂合性缺失、荧光原位杂交和p53分析相结合,改进多灶性膀胱肿瘤的克隆性分析。
Hum Pathol. 2006 Feb;37(2):143-51. doi: 10.1016/j.humpath.2005.10.014. Epub 2005 Dec 15.

引用本文的文献

1
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer.在膀胱尿路上皮癌中,MTAP表达缺失与9p21纯合缺失、不良肿瘤表型及非炎症微环境密切相关。
J Pathol Clin Res. 2025 Jan;11(1):e70012. doi: 10.1002/2056-4538.70012.
2
Background-suppressed live visualization of genomic loci with an improved CRISPR system based on a split fluorophore.基于分裂荧光蛋白的改良 CRISPR 系统对基因组进行背景抑制的活细胞可视化。
Genome Res. 2020 Sep;30(9):1306-1316. doi: 10.1101/gr.260018.119. Epub 2020 Sep 4.
3
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 years.
45岁以下膀胱尿路上皮癌患者的免疫组织化学和分子特征
J Cancer. 2017 Feb 5;8(3):323-331. doi: 10.7150/jca.17482. eCollection 2017.
4
CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.传统透明细胞肾细胞癌中CDKNA2A突变分析、蛋白表达及9号染色体短臂缺失定位:CDKN2A附近存在第二个肿瘤抑制基因的证据
Am J Pathol. 2001 Feb;158(2):593-601. doi: 10.1016/s0002-9440(10)64001-1.
5
Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.乳头状尿路上皮癌患者膀胱单纯性尿路上皮增生中的频繁基因改变。
Am J Pathol. 1999 Mar;154(3):721-7. doi: 10.1016/S0002-9440(10)65318-7.
6
Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization.通过比较基因组杂交检测晚期膀胱癌中的染色体失衡模式。
Am J Pathol. 1998 Nov;153(5):1615-21. doi: 10.1016/S0002-9440(10)65750-1.
7
Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?9号染色体缺失是膀胱移行细胞癌疾病复发的标志物吗?
Br J Cancer. 1998 Jun;77(12):2193-8. doi: 10.1038/bjc.1998.365.
8
DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH.通过流式细胞术和荧光原位杂交检测膀胱癌中的DNA畸变。
Urol Res. 1997;25 Suppl 1:S37-43. doi: 10.1007/BF00942046.
9
Genetics of bladder cancer.膀胱癌的遗传学
J Mol Med (Berl). 1996 Aug;74(8):441-5. doi: 10.1007/BF00217519.
10
A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.一名患有多种原发性恶性肿瘤的患者,其p53基因第8外显子存在一种先天性新发突变。
Br J Cancer. 1996 Jul;74(2):269-73. doi: 10.1038/bjc.1996.350.